Alerts will be sent to your verified email
Verify EmailKILITCH
|
Kilitch Drugs(India)
|
Zim Laboratories
|
Jenburkt Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.31 % | 7.41 % | 18.49 % |
|
5yr average Equity Multiplier
|
1.48 | 1.88 | 1.17 |
|
5yr Average Asset Turnover Ratio
|
0.56 | 0.94 | 0.88 |
|
5yr Avg Net Profit Margin
|
8.44 % | 4.15 % | 18.1 % |
|
Price to Book
|
2.27 | 1.84 | 2.59 |
|
P/E
|
21.02 | 93.56 | 14.71 |
|
5yr Avg Cash Conversion Cycle
|
14.76 Days | 37.07 Days | -32.02 Days |
|
Inventory Days
|
14.42 Days | 68.72 Days | 24.72 Days |
|
Days Receivable
|
136.16 Days | 99.71 Days | 48.38 Days |
|
Days Payable
|
212.73 Days | 143.26 Days | 82.6 Days |
|
5yr Average Interest Coverage Ratio
|
6.02 | 3.96 | 87.2 |
|
5yr Avg ROCE
|
11.26 % | 13.52 % | 24.44 % |
|
5yr Avg Operating Profit Margin
|
12.28 % | 12.21 % | 22.46 % |
|
5 yr average Debt to Equity
|
0.17 | 0.39 | 0.02 |
|
5yr CAGR Net Profit
|
48.72 % | 10.7 % | 14.21 % |
|
5yr Average Return on Assets
|
4.99 % | 4.02 % | 15.8 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.77 % | 30.35 % | 46.64 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.48 % | -2.91 % | -0.92 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kilitch Drugs(India)
|
Zim Laboratories
|
Jenburkt Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|